Eurointervention

Papers
(The H4-Index of Eurointervention is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity181
Double-tap to treat paravalvular leak in high-risk annuli148
Transcatheter left ventriculoplasty141
In search of the origin of the acronym TAVI132
Recanalisation of coronary chronic total occlusions110
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry95
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s92
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement82
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis68
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation61
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure56
Defer-based non-stenting: a promising approach for STEMI56
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document49
The “road travelled”: reflections on the transformation of information exchange in a digital age49
Hybrid coronary revascularisation: the best or the worst of both worlds?49
   Atrial fibrillation and acute coronary syndrome 47
One-month DAPT after acute coronary syndrome: too short or not too short?44
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection42
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial41
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study41
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve39
Redo transcatheter mitral valve replacement in mitral annular calcification38
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes34
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons34
A novel robotic radiation shielding device for interventional cardiology procedures34
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD34
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study33
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis33
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial32
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study32
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement32
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation31
0.079368829727173